文献速递肿瘤 PET/CT核素与放射性配体治疗

18F-MFBG PET/CT是评估转移性嗜铬细胞瘤和副神经节瘤时68Ga-DOTATATE PET/CT的有效替代方法

18 F-MFBG PET/CT Is an Effective Alternative of 68 Ga-DOTATATE PET/CT in the Evaluation of Metastatic Pheochromocytoma and Paraganglioma.
PubMed 文献 · Clin Nucl Med · 2022-10-17

该前瞻性研究纳入28例已知转移性嗜铬细胞瘤和副神经节瘤(PPGL)患者,均在1周内完成18F-MFBG与68Ga-DOTATATE PET/CT检查并比较检出病灶数。18F-MFBG PET/CT在所有患者中均阳性检出转移灶,68Ga-DOTATATE PET/CT在27例(96.4%)患者中阳性。两者共检出686个转移灶,18F-MFBG额外检出33个异常活性灶,68Ga-DOTATATE额外显示16个病灶。作者认为18F-MFBG PET/CT是评估转移性PPGL的有效影像方法,在此临床情境下可作为68Ga-DOTATATE PET/CT的替代。

要点

  • 28例转移性PPGL患者均在1周内完成18F-MFBG与68Ga-DOTATATE PET/CT检查。
  • 18F-MFBG PET/CT在全部患者中阳性检出转移灶,68Ga-DOTATATE在27例(96.4%)中阳性。
  • 两者共检出686个转移灶,18F-MFBG额外检出33个,68Ga-DOTATATE额外显示16个。

核心结论

  • 作者认为18F-MFBG PET/CT是评估转移性PPGL的有效影像方法,在此临床情境下可作为68Ga-DOTATATE PET/CT的替代。

研究设计与样本

  • 前瞻性研究纳入28例已知转移性PPGL患者,所有患者均在1周内完成18F-MFBG与68Ga-DOTATATE PET/CT检查,并比较两种检查检出的病灶数。

主要发现

  • 18F-MFBG PET/CT在所有患者中阳性检出转移灶,68Ga-DOTATATE PET/CT阳性者为27例(96.4%)。
  • 18F-MFBG与68Ga-DOTATATE共检出686个转移灶。
  • 仅18F-MFBG检出33个异常活性灶,仅68Ga-DOTATATE PET/CT显示16个病灶。

关键数值与推荐

  • 现行指南指出,评估转移性PPGL的功能影像选择为68Ga-DOTATATE PET/CT。
  • 18F-MFBG为新型PET示踪剂,是间碘苄胍(MIBG)的类似物。

临床怎么用

  • 作者认为18F-MFBG PET/CT可作为68Ga-DOTATATE PET/CT在转移性PPGL评估中的替代方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The current guidelines state that the functional imaging choice in the evaluation of metastatic pheochromocytoma and paraganglioma (PPGL) is 68 Ga-DOTATATE PET/CT. 18 F-meta-fluorobenzylguanidine ( 18 F-MFBG) is a new PET tracer and an analog of meta-iodobenzylguanidine (MIBG). This study aimed to compare 18 F-MFBG and 68 Ga-DOTATATE PET/CT in patients with metastatic PPGL. PATIENTS AND METHODS: Twenty-eight patients with known metastatic PPGL were prospectively recruited for this study. All patients underwent both 18 F-MFBG and 68 Ga-DOTATATE PET/CT studies within 1 week. Lesion numbers detected were compared between these 2 studies. RESULTS: 18 F-MFBG PET/CT was positive for detecting metastases in all patients, whereas positive results of 68 Ga-DOTATATE PET/CT were in 27 (96.4%) patients. A total of 686 foci of metastatic lesions were detected by both 18 F-MFBG and 68 Ga-DOTATATE imaging. In addition, 33 foci of abnormal activity were only detected by 18 F-MFBG, whereas 16 foci were only shown on 68 Ga-DOTATATE PET/CT. CONCLUSIONS: Our data suggest that 18 F-MFBG PET/CT is an effective imaging method in the evaluation of metastatic PPGL and could be alternative of 68 Ga-DOTATATE PET/CT in this clinical setting.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Wang P, Li T, Cui Y, et al. 18 F-MFBG PET/CT Is an Effective Alternative of 68 Ga-DOTATATE PET/CT in the Evaluation of Metastatic Pheochromocytoma and Paraganglioma. Clin Nucl Med. 2022. PMID: 36252940. doi:10.1097/RLU.0000000000004447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。